Two of the company’s aortic stents have displayed potential to improve patient outcomes post-surgery.

Endospan, a privately held, Israel-based company focused on the endovascular repair of aortic arch disease, announced 1-year ...

The one-year data covers 94 high surgical risk patients across all arms.

Westford USA , Oct. 19, 2023 (GLOBE NEWSWIRE) -- According to SkyQuest, the rising geriatric population prone to aortic disorders fuels demand for stent grafts. The aortic stent grafts market ...

Young patients who receive stents to treat coarctation of the aorta see good hemodynamic results over the long term, combined data from the COAST and COAST II trials show, but late follow-up from ...

A US-based hospital will be testing a new device known as a multilayer stent in patients suffering from aortic aneurysm. Approved in Europe in 2010, the device has already been used to help hundreds ...

Endospan, a privately held company pioneering solutions for the endovascular repair of aortic arch disease, today announced the one-year results of their TRIOMPHE Investigational Device Exemption (IDE ...

… but our independent journalism isn’t free to produce. Help us keep it this way with a tax-deductible donation today. It’s taken two decades, but the global market for stents used to treat abdominal ...

Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed ...

CryoLife, Inc. CRY announced the signing of a distribution and credit facility agreement with Israel-based endovascular stent graft system developer, Endospan. The alliance will add NEXUS (the only ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% ...